Publications

The role of the Innovation Agency is to support the adoption and spread of innovations and improvements which are backed by evidence of impact on efficiency and quality of care.

Annual Review of 2021-2022: read about how we have supported our health and care system and our local economy in the past year.

Reflecting on a year like no other in health and care has been a time to re-evaluate our role in supporting our local systems, partners and national NHS commissioners.

After a year in which our business plan was put to one side as we reached out to support partners locally and nationally, we remain ready to adapt to whatever lies ahead.

Our business plan for 2020 to 2021 is written in summer 2020 as we continue to grapple with the challenges presented by COVID-19.

The Innovation Agency annual report for 2019-2020

This document refreshes the 2018/2020 Innovation Agency Business Plan, describing how we will achieve the updated 2019/20 national programmes, with highlights from the first year. The NHS Long Term Plan names the Academic Health Science Networks (AHSNs), as integral to its delivery and we were relicensed for a further five years, with an additional commission from the Office for Life Sciences (OLS) to deliver Innovation Exchanges, which will support the Accelerated Access Collaborative (AAC) and the spread of Rapid Uptake Products (RUP).

Success stories and highlights from across the North West Coast

The Innovation Agency’s aim is to spread innovations which can improve the quality of health care and reduce costs. We act as honest brokers, mobilising expertise and knowledge across the NHS, academia and industry to help improve lives, save money and drive economic growth through innovation. Our regional partnerships are helping to deliver system change locally in line with the Five Year Forward View; and we are supporting the life sciences economy as reinforced by the Accelerated Access Review.